Bio-Matrix Scientific Group Inc. Receives and Processes First Cord Blood Specimens as Part of the Company’s Quality Assurance Program
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on adult stem cell processing and cryogenic storage, announced today that they have received and processed human umbilical cord blood units as part of their long-term liquid nitrogen storage quality assurance and testing program.